Analyst Ratings for MetLife (met)
met Rating Summary
met Price Target Summary
- Highest: $111.00 (Morgan Stanley)
- Lowest: $80.00 (BMO Capital)
- Average: $103.31
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$103.31 (+5.7%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 74%
Avg. $ Target:
$103.31 (+5.7%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2026 | Piper Sandler | Paul Newsome | Upgrade | Overweight (Neutral) |
110.00 (99.00) |
97.04 (97.70) |
0.68% | Details |
| 1/6/2026 | Evercore ISI » Updated 8/24/2026 |
Thomas Gallagher | Downgrade | In Line (Outperform) |
106.00 (103.00) |
80.32 (97.70) |
21.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
